143 related articles for article (PubMed ID: 31581849)
1. Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503.
Wang W; Hao Y; Li F
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3947-3954. PubMed ID: 31581849
[TBL] [Abstract][Full Text] [Related]
2. Notoginsenoside R1 alleviates TNF-α-induced pancreatic β-cell Min6 apoptosis and dysfunction through up-regulation of miR-29a.
Chen X; Wei R; Jin T; Du H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2379-2388. PubMed ID: 31184222
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy.
Yin Y; Qu H; Yang Q; Fang Z; Gao R
Phytomedicine; 2021 Nov; 92():153749. PubMed ID: 34601220
[TBL] [Abstract][Full Text] [Related]
4. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132.
Fu C; Yin D; Nie H; Sun D
Cell Physiol Biochem; 2018; 51(4):1739-1750. PubMed ID: 30504696
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of notoginsenoside R1 on neuron injury induced by OGD/R through ATF6/Akt signaling pathway].
Hou QL; Wang Y; Li YB; Hu XL; Wang SL
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1167-1174. PubMed ID: 29027434
[TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 protects oxygen and glucose deprivation-induced injury by upregulation of miR-21 in cardiomyocytes.
Liu Z; Wang H; Hou G; Cao H; Zhao Y; Yang B
J Cell Biochem; 2019 Jun; 120(6):9181-9192. PubMed ID: 30552708
[TBL] [Abstract][Full Text] [Related]
7. Notoginsenoside R1 Protects against Neonatal Cerebral Hypoxic-Ischemic Injury through Estrogen Receptor-Dependent Activation of Endoplasmic Reticulum Stress Pathways.
Wang Y; Tu L; Li Y; Chen D; Wang S
J Pharmacol Exp Ther; 2016 Jun; 357(3):591-605. PubMed ID: 26892460
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic-Ischemic Brain Injury.
Tu L; Wang Y; Chen D; Xiang P; Shen J; Li Y; Wang S
Neurochem Res; 2018 Jun; 43(6):1210-1226. PubMed ID: 29696512
[TBL] [Abstract][Full Text] [Related]
9. Notoginsenoside R1 protects WI-38 cells against lipopolysaccharide-triggered injury via adjusting the miR-181a/TLR4 axis.
Qian D; Shao X; Li Y; Sun X
J Cell Biochem; 2019 Dec; 120(12):19764-19774. PubMed ID: 31297873
[TBL] [Abstract][Full Text] [Related]
10. Salidroside mitigates hydrogen peroxide-induced injury by enhancement of microRNA-27a in human trabecular meshwork cells.
Zhao J; Du X; Wang M; Yang P; Zhang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1758-1765. PubMed ID: 31062616
[TBL] [Abstract][Full Text] [Related]
11. Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway.
Li XT; Ma W; Wang XB; Liang Z; Yang JW; He Y; Dai YF; Zhang T; Wang JW; Liu KP; Wang XP; Zhang XK; Li CY; Li JJ; Tang HY; Su P; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2018; 17(7):547-556. PubMed ID: 29992896
[TBL] [Abstract][Full Text] [Related]
12. Notoginsenoside R1 up-regulates microRNA-132 to protect human lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury.
Cong S; Xiang L; Yuan X; Bai D; Zhang X
Int Immunopharmacol; 2019 Mar; 68():137-144. PubMed ID: 30622031
[TBL] [Abstract][Full Text] [Related]
13. Lentinan protects cardiomyocytes against hypoxia-induced injury by regulation of microRNA-22/Sirt1.
Zhang S; Zhao Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3938-3946. PubMed ID: 31581847
[TBL] [Abstract][Full Text] [Related]
14. Bilobalide protects H9c2 cell from oxygen-glucose-deprivation-caused damage through upregulation of miR-27a.
Cao A; Li X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2980-2988. PubMed ID: 31322008
[No Abstract] [Full Text] [Related]
15. Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K/AKT/NF-κB pathway.
Zhan Q; Wu Y; Liu L
Drug Dev Res; 2022 Feb; 83(1):97-104. PubMed ID: 34173680
[TBL] [Abstract][Full Text] [Related]
16. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
Zhu L; Gong X; Gong J; Xuan Y; Fu T; Ni S; Xu L; Ji N
Braz J Med Biol Res; 2020; 53(6):e9346. PubMed ID: 32401923
[TBL] [Abstract][Full Text] [Related]
17. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways.
Meng X; Wang M; Wang X; Sun G; Ye J; Xu H; Sun X
Free Radic Res; 2014 Jul; 48(7):823-38. PubMed ID: 24720662
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.
Li Y; Li Z; Jia Y; Ding B; Yu J
Dig Dis Sci; 2020 May; 65(5):1364-1375. PubMed ID: 31559550
[TBL] [Abstract][Full Text] [Related]
19. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
20. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.
Li H; Zhu J; Xu YW; Mou FF; Shan XL; Wang QL; Liu BN; Ning K; Liu JJ; Wang YC; Mi JX; Wei X; Shao SJ; Cui GH; Lu R; Guo HD
Redox Biol; 2022 Aug; 54():102384. PubMed ID: 35777198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
